Onbrez (indacaterol) / Novartis  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Onbrez (indacaterol) / Novartis
INHALE, NCT02123199: Study of the Impact of Indacaterol (Onbrez®) on the Individual Lives and Health Status of Patients With COPD

Completed
N/A
103
Europe
Indacaterol (Onbrez®) /QAB149
Novartis Pharmaceuticals
Chronic Obstructive Pulmonary Disease
12/13
 
NCT01810692: Preference Tiotropium Respimat Study in COPD

Completed
N/A
150
Europe
Group1:Spiriva® Respimat®, Group2:Hirobriz®/Oslif®/Onbrez® Breezhaler®
Boehringer Ingelheim
Pulmonary Disease, Chronic Obstructive
03/14
03/14
NCT03030638: Drug Utilization Study for Olodaterol

Completed
N/A
27606
Europe
Olodaterol, STRIVERDI, Indacaterol
Boehringer Ingelheim, RTI health solutions, US
Pulmonary Disease, Chronic Obstructive
03/18
03/18

Download Options